2020 Reviewed Company Q2 30/06/2020 Unqualified opinion with an emphasis of matters /Others 2020 Reviewed Company Q1 31/03/2020 Unqualified opinion with an emphasis of matters 2019 Consolidated
reviewed by a certificate public accountant. The Company has and subsidiaries had a net loss of 46 million baht from consolidated financial statements when comparison with the same period at the last year
Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed
Ending 30 Sep 2020 (pro forma consolidated financial) 02/10/2020 08:48 Management Discussion and Analysis Quarter 2 Ending 30 Jun 2020 (Revise Headline) 01/10/2020 20:29 Management Discussion and Analysis
Financial Statement MD&A Financial Statement Revise 2022 Reviewed Company Q3 30/09/2022 2022 Reviewed Consolidated Q3 30/09/2022 2022 Reviewed Company Q2 30/06/2022 2022 Reviewed
Subsidiary (together referred to as “Corporate Group”) would like to clarify on the operating results according to the consolidated financial statements of Year 2019 for the year ended December 31, 2019 as
down. And Medical Vision Co., Ltd. has distributed medical equipment. In the 1 st quarter 2017, it recognized income from complete installation of air tube systems for transfer documents and parcel
focus on expanding hemodialysis Center. Medical Vision Co., Ltd. has distributed medical equipment. Now we can recognize income from complete installation of air tube systems for transfer documents and
discontinued operation U City reported total consolidated revenue of THB 1,791mn in 2Q 2018. This represented an increase of 139.5% YoY or THB 1,043mn from THB 748mn in 2Q 2017. Please note, that the Company has
which was a low profit-margin generating project. The Company took over it as a complete-built project when revenue was ready to be recognized, therefore, risk-free was involved on construction processes